Document is current
Any future updates will be listed below
-
Authors
Mantonico, Malisa Vittoria https://orcid.org/0000-0003-2883-6400
De Leo, Federica
Quilici, Giacomo
Colley, Liam Sean https://orcid.org/0000-0002-3180-017X
De Marchis, Francesco
Crippa, Massimo https://orcid.org/0000-0003-3214-9670
Mezzapelle, Rosanna https://orcid.org/0000-0002-1271-8998
Schulte, Tim
Zucchelli, Chiara
Pastorello, Chiara https://orcid.org/0009-0009-6566-6624
Carmeno, Camilla https://orcid.org/0000-0002-2511-3277
Caprioglio, Francesca https://orcid.org/0000-0001-9505-8157
Ricagno, Stefano
Giachin, Gabriele https://orcid.org/0000-0001-7550-0307
Ghitti, Michela https://orcid.org/0000-0003-4059-0095
Bianchi, Marco Emilio https://orcid.org/0000-0002-5329-6445
Musco, Giovanna https://orcid.org/0000-0002-0469-2994
-
Funding
Funding for this research was provided by:
Associazione Italiana per la Ricerca sul Cancro (IG 2018 - ID 21440, 24118, MFAG27415, IG 2020 – ID. 24702)
GG has received funding from the University of Padova, Starting Grant STARS@UNIPD
Fondazione Buzzi Unicem
- License Information
-
More Information
Article History
Received: 17 May 2023
Accepted: 26 January 2024
First Online: 8 February 2024
Competing interests
: The authors declare the following competing interests: L.S.C. is an employee and M.E.B. is founder and part-owner of HMGBiotech, a company that provides goods and services related to HMGB proteins. The remaining authors declare no competing interests.
